MeSH D020019 - neurocysticercosis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Allergan | Albendazole | Albendazole | 2019-05-20 | |||
| Chartwell Pharmaceuticals | Albendazole | Albendazole | 2020-06-10 | |||
| Cipla | Albendazole | Albendazole | 2018-09-21 | |||
| Dr Reddys Laboratories | Albendazole | Albendazole | 2021-01-26 | |||
| Edenbridge Pharmaceuticals | Albendazole | Albendazole | 2019-05-14 | |||
| Impax Laboratories | Albendazole | Albenza | 1996-06-11 | |||
| MSN Laboratories | Albendazole | Albendazole | 2021-01-21 | |||
| Strides Pharma Global | Albendazole | Albendazole | 2018-12-07 | |||
| Zydus Therapeutics | Albendazole | Albendazole | 2018-12-14 |
Clinical Trials
Historical Success Rate
Phase 1
0%0/0
Phase 2
100%4/4
Phase 3
33%2/6
Approved: 1Overall Success rate: 0%
All Clinical Trials
No data
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use